Astrazeneca Plc Stock Number Of Employees
AZN Stock | 10,468 100.00 0.95% |
AstraZeneca PLC fundamentals help investors to digest information that contributes to AstraZeneca PLC's financial success or failures. It also enables traders to predict the movement of AstraZeneca Stock. The fundamental analysis module provides a way to measure AstraZeneca PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AstraZeneca PLC stock.
AstraZeneca | Number Of Employees |
AstraZeneca PLC Company Number Of Employees Analysis
AstraZeneca PLC's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current AstraZeneca PLC Number Of Employees | 89.9 K |
Most of AstraZeneca PLC's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AstraZeneca PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Competition |
Based on the recorded statements, AstraZeneca PLC is currently employing 89.9 K people. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The number of employees for all United Kingdom stocks is notably lower than that of the firm.
AstraZeneca PLC is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 179,800. AstraZeneca PLC totals roughly 89,900 in number of employees claiming about 50% of equities under Health Care industry.AstraZeneca PLC ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, AstraZeneca PLC's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to AstraZeneca PLC's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
AstraZeneca Fundamentals
Return On Equity | 0.17 | ||||
Return On Asset | 0.085 | ||||
Profit Margin | 0.13 % | ||||
Operating Margin | 0.20 % | ||||
Current Valuation | 184.21 B | ||||
Shares Outstanding | 1.55 B | ||||
Shares Owned By Institutions | 52.59 % | ||||
Price To Book | 5.14 X | ||||
Price To Sales | 3.17 X | ||||
Revenue | 45.81 B | ||||
Gross Profit | 35.73 B | ||||
EBITDA | 13.42 B | ||||
Net Income | 6.9 B | ||||
Total Debt | 28.62 B | ||||
Book Value Per Share | 26.27 X | ||||
Cash Flow From Operations | 10.35 B | ||||
Earnings Per Share | 3.25 X | ||||
Price To Earnings To Growth | 0.73 X | ||||
Target Price | 14033.79 | ||||
Number Of Employees | 89.9 K | ||||
Beta | 0.18 | ||||
Market Capitalization | 162.29 B | ||||
Total Asset | 101.12 B | ||||
Retained Earnings | 4.52 B | ||||
Working Capital | (5.49 B) | ||||
Annual Yield | 0.02 % | ||||
Net Asset | 101.12 B | ||||
Last Dividend Paid | 2.97 |
About AstraZeneca PLC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AstraZeneca PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AstraZeneca PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AstraZeneca PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in AstraZeneca Stock
AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.